Waters... noitazilaicremmoC dna tnempole

Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists
Podcasts & Videos
上一篇:FREE... sgab etsaw dray elbargedoib fo
下一篇:Why... revird remmus kcurtrepus A :el